Cislini Jeff 4
4 · Revolution Medicines, Inc. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
Cislini Jeff
General Counsel
Transactions
- Sale
Common Stock
2025-06-20$39.61/sh−1,912$75,736→ 54,093 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.
- [F2]This transaction was executed in multiple trades in prices ranging from $39.26 to $40.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 49,054 restricted stock units.